Sanofi is continuing to strengthen its long-standing commitment to access to diabetes care in low- and middle-income countries and underserved communities, where comprehensive care has not been widely available, through a series of innovative partnerships with healthcare authorities.
Dr. Joseph Onojaeme, Honourable Commissioner for Health, Delta State; Dr. Philomena Okeowo, Permanent Secretary, Delta State Ministry of Health and Dr. Stephane GOKOU, Global Affordable Strategy Lead, Sanofi General Medicines at the partnership agreement between Sanofi and Delta State Ministry of Health in Asaba, Delta State recently
Sanofi, on 21st
September 2023, signed a two-year collaboration agreement with the Delta State
Government in Nigeria, a milestone marked at a ceremony held in Asaba, the
capital city of Delta State.
Under the collaboration
agreement, the healthcare authorities in Delta State can purchase affordable
Sanofi analogue insulin products. In addition, Sanofi will
provide a digital solution to support physicians, nurses, pharmacists, and
community healthcare practitioners to engage with, educate and monitor patients
to improve diabetes management and support a targeted medical training program
for 700 healthcare professionals.
Speaking on the
collaboration, Dr. Joseph Onojaeme, Honourable Commissioner for Health, Delta State, said: “We face unique
healthcare challenges, and the growing burden of diabetes is indeed a matter of
great concern. Our region bears a heavy burden when it comes to diabetes.
Addressing this challenge is a shared responsibility that transcends boundaries
and sectors. The government of Delta State welcomes this partnership with
Sanofi and we remain committed to the success of the initiative.”
Also
commenting, Dr. Stephane GOKOU, Global Affordable Strategy Lead, Sanofi General Medicines said: “We
see delivering better care and improving the quality-of-life of those living
with diabetes as part of our shared responsibility with healthcare systems. We
are committed to playing our part to address significant unmet need and are
proud to work closely with the Delta State Government in Nigeria. The
partnership we now begin in Delta State builds on a model already deployed in
Ghana. This allows us to learn from previous experience. Working with the
health authorities in Delta State means the interventions we make will be
tailored to address specific local needs and have the greatest impact for those
with diabetes or at risk.”
This joint approach to developing
comprehensive diabetes care with Delta State government becomes imperative as
Africa is predicted to experience the highest increase in diabetes cases
globally. The number of people on the continent living with the disease is
predicted by the International Diabetes Federation to rise by 129% from 24m in
2021 to 55m by 2045. Under-diagnosis is also widespread. IDF estimates suggest
3,623,500₁ adults in Nigeria live with diabetes (3.7% prevalence of
diabetes in adults), the majority being Type 2 while an estimated 51,035²
children and adolescents (0-19 years) live with Type 1 diabetes.
The partnership in Nigeria aligns with the Affordable Access pillar of Sanofi’s approach to corporate social responsibility (CSR). The CSR strategy is one of three major elements of the company’s multi-tiered approach to social impact. This also includes Sanofi Global Health, a non-profit unit aiming to increase access to healthcare in the lowest income countries, and Foundation S, the Sanofi collective dedicated to philanthropy.
About
Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Comments
Post a Comment